Resultados de la búsqueda 121-130 of 14264 for besifloxacin

  1. Médicos y departamentos

    Loscalzo J, et al., eds. Staphylococcal infections. In: Harrison's Principles of Internal Medicine. 21st ed.

  2. Hematología - Ensayos clínicos - Mayo Clinic

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This study is researching an experimental drug called linvoseltamab in combination with other drugs for the treatment of a blood cancer called multiple myeloma.

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Giving cabozantinib, nivolumab, and ipilimumab may work better in treating patients with genitourinary tumors that have no treatment options compared to giving ...

  5. Hematología - Ensayos clínicos - Mayo Clinic

    Giving chemotherapy before a stem cell transplant helps kill cancer cells in the body and helps make room in the patient's bone marrow for new blood-forming ...

  6. Hematología - Ensayos clínicos - Mayo Clinic

    Giving chemotherapy before a stem cell transplant helps kill cancer cells in the body and helps make room in the patient's bone marrow for new blood-forming ...

  7. Enfermedades infecciosas - Ensayos clínicos - Mayo Clinic

    The primary purpose of this study is to examine 1-year survival and rate of secondary infections in COVID-19 patients with and without acute kidney injury (AKI) ...

  8. Hematología - Ensayos clínicos - Mayo Clinic

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...

  9. Hematología - Ensayos clínicos - Mayo Clinic

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...

  10. Oncología (médica) - Ensayos clínicos

    This phase I trial evaluates the safety, effectiveness, and best dose of onvansertib for the treatment of patients with chronic myelomonocytic leukemia that has ...